This research study is currently not recruiting patients.
Do you have Parkinson's disease and experience times when your medication stops working?
What is the purpose of this study?
This research study will see if Tigan®, an approved medication for nausea, helps reduce nausea symptoms caused by Apokyn®. Apokyn® is a medication used to increase the amount of time free from Parkinson's disease symptoms between doses of regularly-prescribed medication.
Can I participate in this study?
You may be eligible for this study if you meet the following criteria:
-
Conditions:Parkinson's Disease, l-dopa, sinemet, levodopa-carbidopa, dyskinesia, swaying, rigidity, Tigan, Apomporphine, Apokyn
-
Age: Between 18 - 100 Years
-
Gender: Male or Female
-
Inclusion Criteria:
-
Exclusion Criteria:
Detail Study Description
The study aims are:
Study Treatments
Placebo, Tigan®
Source: ClinicalTrials.gov
Clinical Study Identifier: TX517
Last Updated: September 2011

Account